Abbott Laboratories (ABT) Fundamental Analysis: Revenue, Earnings & Valuation

7.15 / 10

Outperform

Fundamentals score 7.2/10, rated Outperform. Asset‑MV, Profit‑MV, Cash‑MV, ROA and profit margins rank in top quartiles, indicating strong asset quality and profitability. However, Total profit/EBIT ratio is low, posing a modest risk.

Analysis Checks(9/10)

ROA (%)

Value7.76

Score3/3

Weight7.17%

1M Return0.90%

Net cash flow from operating activities / Operating revenue (%)

Value21.58

Score3/3

Weight14.87%

1M Return1.78%

Profit-MV

Value0.64

Score2/3

Weight10.54%

1M Return1.31%

Net profit margin (%)

Value14.72

Score3/3

Weight6.58%

1M Return0.82%

Total profit / EBIT (%)

Value97.86

Score1/3

Weight-16.87%

1M Return-2.58%

Net cash flow from operating activities / Total liabilities (%)

Value0.28

Score3/3

Weight11.49%

1M Return1.42%

Annualized net profit margin on total assets (%)

Value7.76

Score3/3

Weight7.17%

1M Return0.90%

Asset-MV

Value-0.55

Score3/3

Weight26.91%

1M Return3.20%

Cash-MV

Value0.06

Score2/3

Weight22.97%

1M Return2.64%

Net profit / Total profit (%)

Value77.06

Score3/3

Weight9.18%

1M Return1.16%

Is ABT undervalued or overvalued?

ABT scores 7.15/10 on fundamentals and holds a Discounted valuation at present. Backed by its 12.96% ROE, 14.72% net margin, 27.99 P/E ratio, 3.46 P/B ratio, and -51.37% earnings growth, these metrics solidify its Outperform investment rating.